We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current PSTX market cap is 927.87M. The company's latest EPS is USD -1.2664 and P/E is -7.51.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 9.35M | 25M | 28.14M | 25.97M | 71.75M |
| Operating Income | -36.22M | -25.91M | -24.58M | -31.76M | 19.74M |
| Net Income | -31.78M | -25.35M | -24.27M | -31.37M | 20.24M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 31.24M | 130.49M | 64.7M |
| Operating Income | -85.53M | -126.55M | -141.41M | -59.95M | -129.5M |
| Net Income | -86.53M | -129.78M | -124.97M | -64M | -123.43M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 302.25M | 273.89M | 262.58M | 298.69M | 293.58M |
| Total Liabilities | 178.59M | 170.18M | 177.99M | 237.87M | 206.37M |
| Total Equity | 123.66M | 103.7M | 84.59M | 60.82M | 87.21M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 147M | 371.48M | 269.31M | 351.84M | 273.89M |
| Total Liabilities | 74.33M | 109.52M | 113.1M | 164.24M | 170.18M |
| Total Equity | -149.51M | 261.97M | 156.21M | 187.6M | 103.7M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -63.42M | -92.17M | -15.14M | 23.32M | 13.72M |
| Investing | -8.58M | 39.13M | 24M | -37.2M | -9.55M |
| Financing | 16.13M | 16.13M | -43k | -43k | 699k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -64.39M | -113.33M | -102.54M | -26.77M | -92.17M |
| Investing | -42.59M | -204.43M | 222.38M | -203.33M | 39.13M |
| Financing | 164.37M | 313.94M | 2.52M | 105.16M | 16.13M |
| Market Cap | 927.87M |
| Price to Earnings Ratio | -7.51 |
| Price to Sales Ratio | 14.32 |
| Price to Cash Ratio | 20.84 |
| Price to Book Ratio | 8.94 |
| Dividend Yield | - |
| Shares Outstanding | 97.47M |
| Average Volume (1 week) | 1.75M |
| Average Volume (1 Month) | 1.08M |
| 52 Week Change | 204.15% |
| 52 Week High | 9.65 |
| 52 Week Low | 1.91 |
| Spread (Intraday) | 0.14 (1.47%) |
| Company Name | Poseida Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.poseida.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
